Study of XB010 in Subjects With Solid Tumors
for Locally Advanced or Metastatic Solid Tumors
Sites in Chicago +15 more locations
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT06545331·Phase 1·Recruiting·Listed Aug 2024
Paid Clinical Trials in Illinois
Illinois has 2,847 paid clinical trials enrolling now across cities including Chicago, Peoria and Evanston. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in Illinois include Northwestern Medicine, University of Chicago Medicine and Rush, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
2,519 clinical trials
Get a weekly email when new trials open in Chicago, IL.
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
for Advanced Solid Tumor
Drug: NXP900
Sites in Chicago +12 more locations
Sponsor: Nuvectis Pharma, Inc.
Sex: All·Age: 18+
Code: NCT05873686·Phase 1·Recruiting·Listed May 2023
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
for Ulcerative Colitis
Sites in Chicago +19 more locations
Sponsor: Pfizer
Sex: All·Age: 12 - 17
Code: NCT05287126·Phase 2·Recruiting·Listed Mar 2022
MYLUNG Consortium Part 3: Observational Study
for Carcinoma, Non-Small-Cell Lung
Sites in Chicago Ridge +9 more locations
Sponsor: US Oncology Research
Sex: All·Age: 18+
Code: NCT05885698·Recruiting·Listed Jun 2023
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
for Ulcerative Colitis
Sites in Park Ridge +13 more locations
Sponsor: Takeda
Sex: All·Age: 2 - 17
Code: NCT06405087·Phase 3·Recruiting·Listed May 2024
This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.
for Peripheral Nerve Injury Upper Limb
Sites in Chicago +23 more locations
Sponsor: Neuraptive Therapeutics Inc.
Sex: All·Age: 18 - 80
Code: NCT06616025·Phase 3·Recruiting·Listed Sep 2024
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
for Overactive Bladder (OAB)
Sites in Barrington +14 more locations
Sponsor: FemPulse Corporation
Sex: Female·Age: 21+
Code: NCT07195656·Recruiting·Listed Sep 2025
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
for Chronic Lymphocytic Leukemia (CLL)
Sites in Chicago +14 more locations
Sponsor: Nurix Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05131022·Phase 1·Recruiting·Listed Nov 2021
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
for Multiple System Atrophy
Sites in Chicago +14 more locations
Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Sex: All·Age: 30 - 75
Code: NCT06568237·Phase 2·Recruiting·Listed Aug 2024
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
for Focal Segmental Glomerulosclerosis
Drug: Brivekimig
Sites in Chicago, Hinsdale +14 more locations
Sponsor: Sanofi
Sex: All·Age: 16 - 75
Code: NCT06500702·Phase 2·Recruiting·Listed Jul 2024
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
for Small Cell Lung Cancer
Sites in Peoria +6 more locations
Sponsor: Tempus AI
Sex: All·Age: 18+
Code: NCT05257551·Recruiting·Listed Feb 2022
Vivistim Registry for Paired VNS Therapy (GRASP)
for Upper Extremity Problem
Sites in Evanston, Elk Grove Village +13 more locations
Sponsor: MicroTransponder Inc.
Sex: All·Age: 22+
Code: NCT05301140·Recruiting·Listed Mar 2022
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities
for Periprosthetic Joint Infections
Sites in Skokie +12 more locations
Sponsor: Elute, Inc.
Sex: All·Age: 22+·Accepts healthy volunteers
Code: NCT05361941·Recruiting·Listed May 2022
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
for Advanced Solid Tumors
Sites in Chicago +13 more locations
Sponsor: ModernaTX, Inc.
Sex: All·Age: 12+
Code: NCT05533697·Phase 1, Phase 2·Recruiting·Listed Sep 2022
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
for Primary Membranous Nephropathy
Sites in Chicago +18 more locations
Sponsor: Cerium Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT05696613·Phase 3·Recruiting·Listed Jan 2023
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
for Benign Prostatic Hyperplasia
Sites in Lisle +18 more locations
Sponsor: Rivermark Medical
Sex: Male·Age: 45+
Code: NCT06849258·Recruiting·Listed Feb 2025
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
for Cholangiocarcinoma
Drug: Trametinib
Sites in Chicago +7 more locations
Sponsor: Genfit
Sex: All·Age: 18+
Code: NCT05874414·Phase 1, Phase 2·Recruiting·Listed May 2023
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
for Urothelial Carcinoma
Sites in Chicago +8 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT05562830·Phase 1, Phase 2·Recruiting·Listed Oct 2022
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
for Cerebral Vasospasm
Sites in Evanston +15 more locations
Sponsor: Vesalio
Sex: All·Age: 22+
Code: NCT06893588·Recruiting·Listed Mar 2025
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
for Schizophrenia
Sites in Naperville +21 more locations
Sponsor: Neurocrine Biosciences
Sex: All·Age: 18+
Code: NCT07105111·Phase 4·Recruiting·Listed Aug 2025
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
for Non-Small Cell Lung Cancer
Sites in Peoria +15 more locations
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Sex: All·Age: 18+
Code: NCT06917079·Phase 1·Recruiting·Listed Apr 2025
A Study of PYX-201 in Advanced Solid Tumors
for Solid Tumor
Sites in Chicago +16 more locations
Sponsor: Pyxis Oncology, Inc
Sex: All·Age: 18+
Code: NCT05720117·Phase 1·Recruiting·Listed Feb 2023
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
for Pemphigus Vulgaris
Sites in Chicago +9 more locations
Sponsor: Cabaletta Bio
Sex: All·Age: 18+
Code: NCT04422912·Phase 1, Phase 2·Recruiting·Listed Jun 2020
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
for Familial Adenomatous Polyposis (FAP)
Sites in Chicago +17 more locations
Sponsor: Rapamycin Holdings Inc.
Sex: All·Age: 18+
Code: NCT06950385·Phase 3·Recruiting·Listed Apr 2025
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
for Locally Advanced Solid Tumor
Sites in Chicago +19 more locations
Sponsor: Nuvalent Inc.
Sex: All·Age: 12+
Code: NCT05384626·Phase 1, Phase 2·Recruiting·Listed May 2022
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
for Lower Respiratory Tract Infection
Sites in Chicago +18 more locations
Sponsor: Ansun Biopharma, Inc.
Sex: All·Age: All ages
Code: NCT03808922·Phase 3·Recruiting·Listed Jan 2019
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
for PDAC
Sites in Chicago +17 more locations
Sponsor: Tango Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06922591·Phase 1, Phase 2·Recruiting·Listed Apr 2025
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
for Nausea
Sites in Evanston +11 more locations
Sponsor: Enterra Medical, Inc.
Sex: All·Age: 18+
Code: NCT06464926·Recruiting·Listed Jun 2024
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
for Neuroendocrine Tumors Unresectable
Sites in Chicago +18 more locations
Sponsor: Perspective Therapeutics
Sex: All·Age: 18 - 90
Code: NCT05636618·Phase 1, Phase 2·Recruiting·Listed Dec 2022
EFS of the DUO System for Tricuspid Regurgitation
for Tricuspid Regurgitation
Sites in Chicago +11 more locations
Sponsor: CroiValve Limited
Sex: All·Age: 18+
Code: NCT05913908·Recruiting·Listed Jun 2023
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
for Advanced Hepatocellular Carcinoma
Sites in Chicago +14 more locations
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06600321·Phase 1·Recruiting·Listed Sep 2024
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
for Infertility (IVF Patients)
Sites in Chicago +15 more locations
Sponsor: Granata Bio Corporation
Sex: Female·Age: 18 - 42
Code: NCT07216742·Phase 3·Recruiting·Listed Oct 2025
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
for Refractory Cancer
Drug: Nivolumab
Sites in Chicago +12 more locations
Sponsor: Immatics US, Inc.
Sex: All·Age: 18+
Code: NCT03686124·Phase 1, Phase 2·Recruiting·Listed Sep 2018
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
for Mild Cognitive Impairment
Sites in Chicago +18 more locations
Sponsor: GAP Innovations, PBC
Sex: All·Age: 60 - 90·Accepts healthy volunteers
Code: NCT06584357·Recruiting·Listed Sep 2024
Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference
for Colonic Polyps
Sites in Oak Lawn, Naperville +9 more locations
Sponsor: Capso Vision, Inc.
Sex: All·Age: 45 - 75
Code: NCT07089615·Recruiting·Listed Jul 2025
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
for Melanoma
Drug: Cemiplimab
Sites in Chicago +10 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06413680·Phase 1, Phase 2·Recruiting·Listed May 2024
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
for Advanced Solid Tumors Cancer
Sites in Chicago +9 more locations
Sponsor: Nimbus Wadjet, Inc.
Sex: All·Age: 18 - 99
Code: NCT06898450·Phase 1, Phase 2·Recruiting·Listed Mar 2025
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
for Ulcerative Colitis
Sites in Park Ridge +7 more locations
Sponsor: Takeda
Sex: All·Age: 2+
Code: NCT05442567·Phase 3·Recruiting·Listed Jul 2022
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
for Advanced Solid Tumors
Sites in Chicago +9 more locations
Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Sex: All·Age: 18+
Code: NCT06480552·Phase 1·Recruiting·Listed Jun 2024
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
for Solid Tumor
Sites in Chicago +4 more locations
Sponsor: Eisai Inc.
Sex: All·Age: 18+
Code: NCT04300556·Phase 1, Phase 2·Recruiting·Listed Mar 2020